Next Article in Journal
Engineering Lipid Nanoparticles to Enhance Intracellular Delivery of Transforming Growth Factor-Beta siRNA (siTGF-β1) via Inhalation for Improving Pulmonary Fibrosis Post-Bleomycin Challenge
Next Article in Special Issue
Transport of Drugs Through Biological Barriers—An Asset or Risk
Previous Article in Journal
Computational Evaluation of Improved HIPEC Drug Delivery Kinetics via Bevacizumab-Induced Vascular Normalization
Previous Article in Special Issue
Log BB Prediction Models Using TLC and HPLC Retention Values as Protein Affinity Data
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(2), 156; https://doi.org/10.3390/pharmaceutics17020156
Action Date Notes Link
article xml file uploaded 24 January 2025 08:56 CET Original file -
article xml uploaded. 24 January 2025 08:56 CET Update https://www.mdpi.com/1999-4923/17/2/156/xml
article pdf uploaded. 24 January 2025 08:56 CET Version of Record https://www.mdpi.com/1999-4923/17/2/156/pdf
article supplementary file uploaded. 24 January 2025 08:56 CET - https://www.mdpi.com/1999-4923/17/2/156#supplementary
article html file updated 24 January 2025 08:58 CET Original file https://www.mdpi.com/1999-4923/17/2/156/html
Back to TopTop